Catalyst
Slingshot members are tracking this event:
Phase 2 Spruce trial evaluating the combination of apatorsen with carboplatin and pemetrexed overall survival results are expected in July 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| OGXI | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 21, 2017
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT01829113?term=OncoGenex&rank=19
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2 Top-line Data, Spruce Trial, Apatorsen, Carboplatin, Pemetrexed, Combination
